Back to Search Start Over

P-23 Phase II study (daNIS-3) of the anti–TGF-β monoclonal antibody NIS793 and other new investigational drug combinations with standard-of-care therapy vs standard-of-care alone in patients with second-line metastatic colorectal cancer

Authors :
N. Segal
F. Rivera
C. Tournigand
S. Kasper
Y. Chen
P. Deshpande
R. Messmann
S. Kopetz
Publication Year :
2022

Subjects

Subjects :
Oncology
Medizin
Hematology

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....f9f972215ae9d49dfdcdece9b528491d

Tools

Authors Abstract Subjects Details